TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18237866

Group type: EXPERIMENTAL
Intervention: Oral prednisone (P)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Swallowed fluticasone (F)
Number of subjects: 80
Study: 15936062

Group type: EXPERIMENTAL
Intervention: Methamphetamine (10 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Zolpidem (10 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Combination of Methamphetamine (10 mg) and Zolpidem (10 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo for both Methamphetamine and Zolpidem
Number of subjects: 8
Study: 12955029

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node (SLN) biopsy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine axillary dissection
Number of subjects: 0
Study: 10543415

Group type: EXPERIMENTAL
Intervention: 10 mg medrogestone (Prothil)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (group A)
Number of subjects: 23
Study: 8905423

Group type: EXPERIMENTAL
Intervention: Corticotropin stimulation test during septic shock
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Corticotropin stimulation test after recovery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison of APACHE II scores
Number of subjects: 20
Study: 1907740

Group type: EXPERIMENTAL
Intervention: CRH i.v. (200 micrograms)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Human CRH and ovine CRH (100-200 micrograms i.v.)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: CRH
Number of subjects: 22
Study: 6352020

Group type: EXPERIMENTAL
Intervention: Weekly high‐dose asparaginase
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard treatment (vincristine, prednisone, doxorubicin)
Number of subjects: 72
Study: 31319653

Group type: EXPERIMENTAL
Intervention: Serum bilirubin levels (measured using genetic variants)
Number of subjects: 33598

Group type: EXPERIMENTAL
Intervention: Genetic variant rs12993249 (USP40)
Number of subjects: 33598
Study: 29743330

Group type: EXPERIMENTAL
Intervention: Higher intensity education and communication skills intervention
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Lower intensity education-only intervention
Number of subjects: 1600
Study: 27049778

Group type: EXPERIMENTAL
Intervention: Laparoscopic Cholecystectomy (LC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Active Nonoperative Therapy (NO) with low-dose neuromodulator (amitriptyline 25 mg/day)
Number of subjects: 30
Study: 24867013

Group type: EXPERIMENTAL
Intervention: Sphincterotomy
Number of subjects: 214

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Dual sphincterotomy
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Biliary sphincterotomy
Number of subjects: 214

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Biliary sphincterotomy (observational study)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Dual sphincterotomy (observational study)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: No sphincterotomy (observational study)
Number of subjects: 214
Study: 22240564

Group type: EXPERIMENTAL
Intervention: Moderated online support group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Peer-led online support group
Number of subjects: 50
Study: 20136677

Group type: EXPERIMENTAL
Intervention: Camel thorn distillate (n = 49)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo (n = 44)
Number of subjects: 93
Study: 18709235

Group type: EXPERIMENTAL
Intervention: Daily iron supplementation (12.5mg Fe/day)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Weekly iron supplementation (25mg Fe/week)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 297
Study: 15957672

Group type: EXPERIMENTAL
Intervention: Individual treatment for female alcoholics
Number of subjects: 109

Group type: COMPARATOR
Intervention: Couple treatment for female alcoholics
Number of subjects: 109
Study: 12575967

Group type: EXPERIMENTAL
Intervention: Endovascular brachytherapy (EVBT) with iridium 192; 14 Gy at a depth of the radius of the vessel +2 mm
Number of subjects: 204

Group type: COMPARATOR
Intervention: None (control group with stents without EVBT)
Number of subjects: 204

Group type: COMPARATOR
Intervention: None (control group undergoing EVBT after simple balloon angioplasty)
Number of subjects: 204
Study: 10769854

Group type: EXPERIMENTAL
Intervention: Chloral hydrate and hydroxyzine (CH-H)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Chloral hydrate, meperidine, and hydroxyzine (CH-D-H)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Midazolam (M)
Number of subjects: 300
Study: 9277245

Group type: EXPERIMENTAL
Intervention: Logbook intervention for trial patients
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Logbook intervention for care-professionals
Number of subjects: 71

Group type: COMPARATOR
Intervention: Comparison group (no logbook)
Number of subjects: 71
Study: 8394861

Group type: COMPARATOR
Intervention: Sodium stibogluconate (Sbv) at 20 mg/kg/day for 30 days (group S)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Sodium stibogluconate (Sbv) at 20 mg/kg/day plus aminosidine at 15 mg/kg/day for 17 days (group AS)
Number of subjects: 200
Study: 3089361

Group type: EXPERIMENTAL
Intervention: Nystatin suspension or pastilles (new formulation)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Nystatin pastilles
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Concomitant treatment of dentures
Number of subjects: 50
Study: 31863911

Group type: EXPERIMENTAL
Intervention: Male dog allergen extract
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Female dog allergen extract
Number of subjects: 22

Group type: COMPARATOR
Intervention: Mix of dog components
Number of subjects: 22
Study: 29855364

Group type: EXPERIMENTAL
Intervention: Breastfeeding maintenance for at least 6 months
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Breastfeeding maintenance for at least 12 months
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Breastfeeding maintenance for at least 24 months
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Factors associated with breastfeeding maintenance at 6 months
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Factors associated with breastfeeding maintenance at 12 months
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Factors associated with breastfeeding maintenance at 24 months
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Infant not using a pacifier
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Maternal grandmother breastfeeding support
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding duration
Number of subjects: 228
Study: 28619025

Group type: EXPERIMENTAL
Intervention: Usual care plus an additional face-to-face consultation and follow-up telephone call with a 'healthy lifestyle clinician'
Number of subjects: 540

Group type: COMPARATOR
Intervention: Usual care for chronic disease risks provided in routine consultations
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Healthy lifestyle clinician intervention
Number of subjects: 540
Study: 26683627

Group type: EXPERIMENTAL
Intervention: Core lab interpretation of stress echocardiography
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Exercise stress echocardiography
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Pharmacologic stress echocardiography
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Good or excellent image quality
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Poor or fair image quality
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Discordant interpretations in patients with no or mild LV myocardial ischemia
Number of subjects: 81
Study: 23246393

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 111
Study: 21977987

Group type: EXPERIMENTAL
Intervention: Pravastatin treatment
Number of subjects: 5244

Group type: EXPERIMENTAL
Intervention: Top SNP (rs445925)
Number of subjects: 5244

Group type: EXPERIMENTAL
Intervention: Second top SNP (rs6511720)
Number of subjects: 5244

Group type: EXPERIMENTAL
Intervention: GWAS analysis
Number of subjects: 5244
Study: 18280835

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment, sc 66 µg/Kg/d
Number of subjects: 25

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 25
Study: 17128839

Group type: EXPERIMENTAL
Intervention: Intramuscular (i.m.) vaccination (40 microgram, 2 ml)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Subcutaneous (s.c.) vaccination (10 microgram, 0.5 ml)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Intradermal (i.d.) vaccination (10 microgram, 0.5 ml)
Number of subjects: 34
Study: 12957728

Group type: EXPERIMENTAL
Intervention: Patients with one vessel disease (VD)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Patients with two vessel disease (VD)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Patients with three vessel disease (VD)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Patients with CAD
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Patients with more diseased vessels
Number of subjects: 101

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 101
Study: 10856529

Group type: EXPERIMENTAL
Intervention: Colestipol-niacin
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 9170692

Group type: EXPERIMENTAL
Intervention: Postpartum public health nurse telephone visit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clerk call
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (mailed out information package)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telephone visit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parent-baby groups attendance
Number of subjects: 0
Study: 8228158

Group type: EXPERIMENTAL
Intervention: Compliant physicians (n=44)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Noncompliant physicians (n=5)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control physicians (n=21)
Number of subjects: 70
Study: 31178989

Group type: EXPERIMENTAL
Intervention: Occupational Therapy (OT) + Virtual Reality (VR)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Occupational Therapy (OT)
Number of subjects: 26
Study: 29380613

Group type: EXPERIMENTAL
Intervention: 3Mix‐MP (metronidazole, minocycline, ciprofloxacin)
Number of subjects: 22

Group type: COMPARATOR
Intervention: 3Mix‐MP‐R (metronidazole, clindamycin, ciprofloxacin)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 3Mix‐MP and 3Mix‐MP‐R
Number of subjects: 22
Study: 26111868

Group type: EXPERIMENTAL
Intervention: 200,000 IU vitamin D
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both groups (vitamin D and placebo)
Number of subjects: 50
Study: 24597840

Group type: EXPERIMENTAL
Intervention: Luseogliflozin 0.5 mg
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Luseogliflozin 2.5 mg
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Luseogliflozin 5 mg
Number of subjects: 239

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Luseogliflozin (all doses)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 239
Study: 22386848

Group type: EXPERIMENTAL
Intervention: User Centred Critical Care Discharge Information Pack (UCCDIP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 19049846

Group type: EXPERIMENTAL
Intervention: Enoxaparin (1 mg/kg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sodium chloride (NaCl)
Number of subjects: 100
Study: 17953640

Group type: EXPERIMENTAL
Intervention: HAL-PDT
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: MAL-PDT
Number of subjects: 18

Group type: COMPARATOR
Intervention: HAL-PDT and MAL-PDT
Number of subjects: 18
Study: 16366812

Group type: EXPERIMENTAL
Intervention: Urine assays
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Timeline Follow Back (TLFB) self-report measure
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Adolescent Drug Abuse Diagnosis Scale self-report measure
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Diagnostic Interview Schedule for Children (DISC)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: DISC marijuana abuse/dependence diagnostic criteria
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: DISC cocaine abuse/dependence diagnostic criteria
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Baseline TLFB assessments among African American participants
Number of subjects: 190
Study: 12163983

Group type: COMPARATOR
Intervention: Mg(2+) supplementation (10 mmol for 3 days, 20 mmol for 3 days, 30 mmol for 14 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Mg(2+) supplementation
Number of subjects: 12
Study: 9588417

Group type: EXPERIMENTAL
Intervention: Intraaortic balloon counterpulsation (IABC) with 20 ml inflation volume
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intraaortic balloon counterpulsation (IABC) with 40 ml inflation volume
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (IABC off)
Number of subjects: 18
Study: 8560129

Group type: EXPERIMENTAL
Intervention: Temazepam 15-30 mg/day
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo or behavior therapy
Number of subjects: 15
Study: 2529524

Group type: EXPERIMENTAL
Intervention: Pfannenstiel's incision
Number of subjects: 119

Group type: COMPARATOR
Intervention: Mouchel's low transverse abdominal incision (LTA)
Number of subjects: 119
Study: 320917

Group type: EXPERIMENTAL
Intervention: clemastine fumarate 2.68 mg
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: chlorpheniramine 4 mg
Number of subjects: 106

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 106
Study: 31318074

Group type: EXPERIMENTAL
Intervention: Overexpression of Fvsdh gene
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (non-transgenic strains)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (strain T3)
Number of subjects: 5
Study: 31729347

Group type: EXPERIMENTAL
Intervention: Nerve block (transtracheal and bilateral recurrent laryngeal nerve block)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Atomized lignocaine (local anesthesia atomizer)
Number of subjects: 30
Study: 26988955

Group type: EXPERIMENTAL
Intervention: Pulmonary artery stenting (PA stenting)
Number of subjects: 1183
Study: 25267008

Group type: EXPERIMENTAL
Intervention: Telemonitoring group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 22659250

Group type: EXPERIMENTAL
Intervention: T-gel
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: T-gel + DMPA
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: T-gel + dutasteride
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 20084316

Group type: EXPERIMENTAL
Intervention: Music therapy (weekly sessions for twelve weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 0
Study: 17961301

Group type: EXPERIMENTAL
Intervention: C.E.R.A. 50 microg
Number of subjects: 84

Group type: COMPARATOR
Intervention: Darbepoetin alfa 50 microg
Number of subjects: 84
Study: 15381386

Group type: EXPERIMENTAL
Intervention: Clopidogrel treatment (75 mg/day; 7 days)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Clopidogrel treatment
Number of subjects: 15
Study: 11432884

Group type: EXPERIMENTAL
Intervention: Initial lumbar puncture and intrathecal chemotherapy performed after 1 week of prednisolone sensitivity testing (day 8).
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Good responders to prednisolone (84.5% of patients).
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Poor responders to prednisolone (15.5% of patients).
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: CNS relapse as first adverse event.
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Bleeding into the CSF at the time of the day 8 lumbar puncture.
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Leukemic blasts identified at the day 8 lumbar puncture.
Number of subjects: 418
Study: 9557981

Group type: EXPERIMENTAL
Intervention: New automated approach for detecting SOAEs
Number of subjects: 0
Study: 7983234

Group type: EXPERIMENTAL
Intervention: 0.6 mg nitroglycerin (NTG) sublingually
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2590601

Group type: EXPERIMENTAL
Intervention: Phentolamine 5 mg i.v.
Number of subjects: 10
Study: 31741168

Group type: EXPERIMENTAL
Intervention: Routine fine-needle aspiration cytology (FNAC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Watchful surveillance
Number of subjects: 0
Study: 31589615

Group type: EXPERIMENTAL
Intervention: Antimuscarinics
Number of subjects: 1000000

Group type: EXPERIMENTAL
Intervention: Alpha-adrenergic blockers
Number of subjects: 1000000

Group type: EXPERIMENTAL
Intervention: Overall healthcare seeking for LUTS
Number of subjects: 1000000
Study: 27797565

Group type: EXPERIMENTAL
Intervention: Traumatic stress reactions including PTSD and internalizing and externalizing symptoms
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Family cohesion
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Family conflict
Number of subjects: 200
Study: 25766261

Group type: EXPERIMENTAL
Intervention: Glucose-sparing regimen
Number of subjects: 180

Group type: COMPARATOR
Intervention: Glucose-based therapy
Number of subjects: 180

Group type: COMPARATOR
Intervention: Comparison of glucose-sparing regimen vs glucose-based therapy
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 180
Study: 23833045

Group type: EXPERIMENTAL
Intervention: Usual medical care plus physical activity (12-week home-based programme)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual medical care alone (control)
Number of subjects: 200
Study: 22153779

Group type: EXPERIMENTAL
Intervention: Zolpidem (30 days)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo (30 days)
Number of subjects: 103
Study: 19579599

Group type: EXPERIMENTAL
Intervention: Basal CEA in CRC patients (17.3 ng% ± 1.67)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Basal CEA for Dukes' A, B, C
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Basal CEA in primary CRC diagnosis
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Basal CEA in advanced disease detection
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Basal CEA < or =5 ng%
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Basal CEA above 15 ng%
Number of subjects: 200
Study: 17465287

Group type: EXPERIMENTAL
Intervention: Testing order (vulva first vs. thumb first)
Number of subjects: 33
Study: 16422841

Group type: EXPERIMENTAL
Intervention: Sexual Function Questionnaire (SFQ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Data from five clinical trials and two general population surveys
Number of subjects: 0
Study: 11843745

Group type: EXPERIMENTAL
Intervention: Cyclizine 50 mg
Number of subjects: 74

Group type: COMPARATOR
Intervention: Ondansetron 4 mg
Number of subjects: 74
Study: 10740421

Group type: EXPERIMENTAL
Intervention: Conversion to sinus rhythm (SR) by means of direct current cardioversion and maintaining it
Number of subjects: 121

Group type: COMPARATOR
Intervention: Leaving patients with atrial fibrillation (AF) treated by rate control and antithrombotic treatment
Number of subjects: 121
Study: 8746907

Group type: EXPERIMENTAL
Intervention: Physical training for 8 weeks
Number of subjects: 12
Study: 1946181

Group type: EXPERIMENTAL
Intervention: Alcohol (0.5 g/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Alcohol (1.0 g/kg)
Number of subjects: 12
Study: 7098380

Group type: EXPERIMENTAL
Intervention: 20 mg intravenous (IV) propranolol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 80 mg oral propranolol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 80 mg oral propranolol (multiple doses every 12 h)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 80 mg oral propranolol (single dose)
Number of subjects: 6
Study: 31608520

Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 34

Group type: COMPARATOR
Intervention: Ultrasonic method
Number of subjects: 34
Study: 28027453

Group type: EXPERIMENTAL
Intervention: OSTAP-Pethidine (treated with 1% pethidine)
Number of subjects: 79

Group type: COMPARATOR
Intervention: OSTAP-Placebo (treated with normal saline)
Number of subjects: 79
Study: 25934242

Group type: EXPERIMENTAL
Intervention: Lumboperitoneal shunt surgery (immediate treatment group)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Postponed treatment group (surgery postponed for 3 months)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 93
Study: 23280243

Group type: EXPERIMENTAL
Intervention: losartan
Number of subjects: 30

Group type: COMPARATOR
Intervention: propranolol
Number of subjects: 30
Study: 20622199

Group type: EXPERIMENTAL
Intervention: Golimumab plus methotrexate (background therapy) every 4 weeks through week 52
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo plus methotrexate (background therapy) every 4 weeks through week 52
Number of subjects: 302
Study: 18799512

Group type: EXPERIMENTAL
Intervention: Tele-assistance (TA)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Tele-assistance (TA) in COPD patients
Number of subjects: 240

Group type: COMPARATOR
Intervention: Traditional care
Number of subjects: 240
Study: 17986338

Group type: EXPERIMENTAL
Intervention: Podiatry led foot care
Number of subjects: 34

Group type: COMPARATOR
Intervention: No care (control)
Number of subjects: 34
Study: 15516003

Group type: EXPERIMENTAL
Intervention: Percutaneous bone graft (n=15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Open bone graft (n=15)
Number of subjects: 30
Study: 11504165

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg once a day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Acebutolol (400 mg once a day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 9766270

Group type: EXPERIMENTAL
Intervention: Moyamoya disease patients
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Affected side
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hemorrhagic attack
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Chronic hypoperfusion
Number of subjects: 9